Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Intestinal movement" refers to the coordinated contraction and relaxation of smooth muscle in the gastrointestinal tract, enabling propulsion and mixing of luminal contents. This process, termed peristalsis, relies on the integration of electrical activity generated by interstitial cells of Cajal (the gut "pacemakers"), neurotransmitter release from enteric neurons (notably acetylcholine, serotonin, nitric oxide), and hormonal signals (such as motilin and secretin)[3][4][8]. There is no single molecular target for "intestinal movement"; rather, it is the result of interaction among various cellular and molecular systems that regulate muscle contraction and relaxation across different segments of the GI tract[1][6][7].
Stimulation or inhibition of neurotransmitter release (acetylcholine, serotonin, nitric oxide); Modulation of smooth muscle contractility (via calcium channel, G protein-coupled receptor signaling, kinase pathways); Agonism or antagonism of specific receptors (motilin receptor, serotonin 5-HT4 receptor, opioid receptors).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal movement.